|
|
M D. Michaelson, MD, PhD
Publications
- Zama IN, Hutson TE, Elson P, Cleary JM, Choueiri TK, Heng DY, Ramaiya N, Michaelson MD, Garcia JA, Knox JJ, Escudier B, Rini BI.Sunitinib rechallenge in metastatic renal cell carcinoma patients.Cancer. 2011 Dec 1;116(23):5400-6.
21105118 - Patil S, Figlin RA, Hutson TE, Michaelson MD, Négrier S, Kim ST, Huang X, Motzer RJ.Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cel
20657034 - Saylor PJ, Kaufman DS, Michaelson MD, Lee RJ, Smith MR.Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer.J Urol. 2010 Jun;183(6):2200-5.
20399451 - Cella D, Michaelson MD, Bushmakin AG, Cappelleri JC, Charbonneau C, Kim ST, Li JZ, Motzer RJ.Health-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-alpha in a phase III trial: final results and
20104222 - Faris JE, Michaelson MD.Targeted therapies: Sunitinib versus interferon-alpha in metastatic RCC.Nat Rev Clin Oncol. 2010 Jan;7(1):7-8.
20029441 - Hulick P, Zimmer M, Margulis V, Skates S, Hamel M, Dahl DM, Michaelson DM, Libermann T, Signoretti S, Carney W, Wood C, Iliopoulos O.Blood Levels of Carbonic Anhydrase 9 Correlate with Clear Cell Renal Cell Carcinoma Activity.Clin. Proteomics.;5(1):37-45.
- Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-del-Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, Chen I, Huang X, Figlin RA.Overall survival and updated results for
19487381 - Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwar
19555582 - Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwar
19555584 - Saylor PJ, Michaelson MD.New treatments for renal cell carcinoma: targeted therapies.J Natl Compr Canc Netw. 2009 Jun;7(6):645-56. Review.
19555586 - Motzer RJ, Bukowski RM, Figlin RA, Hutson TE, Michaelson MD, Kim ST, Baum CM, Kattan MW.Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.Cancer. 2008 Oct 1;113(7):1552-8.
18720362 - de Bazelaire C,Alsop DC,George D,Pedrosa I,Wang Y,Michaelson MD,Rofsky NM.Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.Clin Can
18765547 - Rini BI, Michaelson MD, Rosenberg JE, Bukowski RM, Sosman JA, Stadler WM, Hutson TE, Margolin K, Harmon CS, DePrimo SE, Kim ST, Chen I, George DJ.Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic ren
18669461 - Michaelson MD,Iliopoulos O,McDermott DF,McGovern FJ,Harisinghani MG,Oliva E.Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.N Engl J Med. 2008 May 29;358(22):2389-96.
18509125 - Michaelson MD,Cotter SE,Gargollo PC,Zietman AL,Dahl DM,Smith MR.Management of complications of prostate cancer treatment.CA Cancer J Clin. 2008 Jul-Aug;58(4):196-213. Review.
18502900 - Rixe O, Bukowski RM, Michaelson MD, Wilding G, Hudes GR, Bolte O, Motzer RJ, Bycott P, Liau KF, Freddo J, Trask PC, Kim S, Rini BI.Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.Lancet Oncol. 2007 No
17959415 - Motzer RJ, Michaelson MD, Rosenberg J, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Wilding G.Sunitinib efficacy against advanced renal cell carcinoma.J Urol. 2007 Nov;178(5):1883-7.
17868732 - Deprimo SE, Bello CL, Smeraglia J, Baum CM, Spinella D, Rini BI, Michaelson MD, Motzer RJ.Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related protein
17605814 - Michaelson MD.ASCO 2006 highlights: Targeted therapy for renal cell carcinoma.Cancer Treat Rev. 2007 Jun;33(4):381-90.
17367939 - Michaelson MD, Kaufman DS, Lee H, McGovern FJ, Kantoff PW, Fallon MA, Finkelstein JS, Smith MR.Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.J Clin Onc
17369566 - Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA.Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.N Engl J Med. 2007 Jan 11;356(2):115-24
17215529 - McDougal WS, Tolkoff-Rubin NE, Michaelson MD, Mueller PR, Braaten K.Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys.N Engl J Med. 2006 Sep 14;355(11):1161-7.
16971723 - Michaelson MD, Kaufman DS, Kantoff P, Oh WK, Smith MR.Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.Cancer. 2006 Aug 1;107(3):530-5.
16804927 - de Bazelaire C, Rofsky NM, Duhamel G, Zhang J, Michaelson MD, George D, Alsop DC.Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement.Eur Radiol. 2006 Sep;16(9):2083-91.
16583215 - Campbell J, Rosenthal DI, Raskin KA, Hornicek FJ, Michaelson MD.Use of an arterial tourniquet to achieve complete radiofrequency ablation of a renal metastasis.J Vasc Interv Radiol. 2006 Jun;17(6):1051-5.
16778241 - Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD.Sunitinib in patients with metastatic renal cell carcinoma.JAMA. 2006 Jun 7;295(21):2516-24
16757724 - Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ, Bello CL, Theuer CP, George DJ, Rini BI.Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and
16330672 - Michaelson MD, Smith MR.Bisphosphonates for treatment and prevention of bone metastases.J Clin Oncol. 2005 Nov 10;23(32):8219-24.
16278476 - Motzer RJ, Rini BI, Michaelson MD, Redman BG, Hudes GR, Wilding G, Bukowski RM, George DJ, Kim T, Baum CM.Phase 2 trials of SU11248 show antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma (RCC).Survey Methodol. 200
- De Bazelaire C, Rofsky NM, Duhamel G, Michaelson MD, George D, Alsop DC.Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).Acad Radiol. 2005 Mar;12(3):347-57.
15766695 - Katz-Brull R, Rofsky NM, Morrin MM, Pedrosa I, George DJ, Michaelson MD, Marquis RP, Maril M, Noguera C, Lenkinski RE.Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectros
15572523 - Michaelson MD, Smith MR, Talcott JA.Prostate cancer (metastatic).Clin Evid. 2003 Dec(10):1012-22.
15555135 - Michaelson MD, Marujo RM, Smith MR.Contribution of androgen deprivation therapy to elevated osteoclast activity in men with metastatic prostate cancer.Clin Cancer Res. 2004 Apr 15;10(8):2705-8.
15102674 - Michaelson MD, Smith MR.The role of bisphosphonates in the management of metastatic prostate cancer.Curr Oncol Rep. 2003 May;5(3):245-9.
12667423 - Michaelson MD, Talcott JA, Smith MR.Prostate cancer: metastatic.Clin Evid. 2002 Dec(8):881-90.
12603918 - Michaelson MD, Ryan DP, Fuchs CS, Supko JG, Garcia-Carbonero R, Paul Eder J, Clark JW.A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.Cancer. 2003 Jan 1;97(1):148-54.
12491516
|
